Skip to Main Content

Cannabis News Box

Cannabis News Box

Cannabis News Box

https://globenewswire.com/news-release/2018/06/25/1529165/0/en/GW-Pharmaceuticals-plc-and-its-U-S-Subsidiary-Greenwich-Biosciences-Announce-FDA-Approval-of-EPIDIOLEX-cannabidiol-oral-solution-the-First-Plant-derived-Cannabinoid-Prescription-Me.html

CEO of GW Pharma talks about Epidiolex getting FDA approval

Bethan Rose Jenkins, Cannabis News Writer/Editorial July 2, 2018

On Monday, Justin Gover hit a milestone in his career. He is the CEO of GW Pharmaceuticals – a company that created a cannabis-based medicine called Epidiolex. Not only is Epidiolex being used to treat...

Cannabis for IBD – Cannabinoids show promise for treating, relieving and preventing inflammation

Bethan Rose Jenkins, Cannabis News Writer/Editorial June 24, 2018

People with inflammatory bowel disease (IBD) could soon be treated using cannabis. Human therapy studies and epidemiologic data have shown how cannabinoids could ease the symptoms of IBD.  A 2010 study...

Load More Stories